The effects of a new coronary vasocilator (BAY-a-1040, Nifedipine) on the coronary and systemic haemodynamics in the anaesthetized dog.
D000771:Anesthesia, Intravenous; D000818:Animals; D001786:Blood Glucose; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003998:Dicarboxylic Acids / Q000494:pharmacology; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007275:Injections, Intravenous; D009206:Myocardium / Q000378:metabolism; D009578:Nitrobenzenes / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D011652:Pulmonary Circulation / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D001786:Blood Glucose; D003998:Dicarboxylic Acids; D005230:Fatty Acids, Nonesterified; D009578:Nitrobenzenes; D011725:Pyridines